Drug Approval | October 26, 2022
Zydus receives final approval from USFDA for Micafungin for Injection
Micafungin for Injection had annual sales of US $99 million in the United States according to IQVIA data
Micafungin for Injection had annual sales of US $99 million in the United States according to IQVIA data
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in
The training center will focus on providing radiation oncologists, radiotherapy technologists, and medical physicists with the necessary skills
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Sildenafil for Oral Suspension had annual sales of USD 65 million in the United States according to IQVIA data (IQVIA MAT Aug 2022).
Sud has more than 32 years of work experience with different companies like Clivient, Jubilant Life Sciences, Piramal Enterprises, Parabolic Drugs, Orchid Chemicals and Pharmaceuticals, Ranbaxy Labs, and Lupin
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
Lenalidomide is used to treat various types of cancers.
Subscribe To Our Newsletter & Stay Updated
